SCHEMBL23901463

SCHEMBL23901463

Cc1cc(-c2ccco2)nc2c(C(=O)NC(=O)C(C)(C)C3CC3)ncn12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.39
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
KDM4E B2RXH2 12/20 0.39
HSD17B10 Q99714 9/20 0.39
HPGD P15428 7/20 0.39
CASP1 P29466 6/20 0.39
CASP7 P55210 6/20 0.39
ALOX15 P16050 4/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
TSHR P16473 2/20 0.39
CYP2C19 P33261 2/20 0.39
USP2 O75604 2/20 0.39
CYP3A4 P08684 1/20 0.39
MAPK1 P28482 1/20 0.39
MAPT P10636 5/20 0.38
NPSR1 Q6W5P4 3/20 0.38
TP53 P04637 1/20 0.38
TDP1 Q9NUW8 5/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19438181 0.79 KDM4E (0.45) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL23901467 0.78 IRAK4 (0.34) ALDH1A1HSD17B10MAPK1
SCHEMBL23901519 0.75 KDM4E (0.42) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL19449384 0.72 WDR5 (0.36) POLB
SCHEMBL19449391 0.71 ANO1 (0.35)
SCHEMBL30532267 0.70 ATR (0.43) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL17741205 0.70 ATR (0.43) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL19438382 0.69 ANO1 (0.36) KDM4EMAPK1MAPTTDP1POLB
SCHEMBL19437972 0.69 KDM4E (0.38) ALDH1A1KMT2AKDM4EHSD17B10HPGD
SCHEMBL19438031 0.69 TYRO3 (0.38) CYP2C9CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210309661-A1 IMIDAZO[1,5-a]PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS BIAL - R&D INVESTMENTS, S.A. (PT) 2021-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210309661-A1 IMIDAZO[1,5-a]PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS GBA1, GAA, GBA2 ALDH1A1 1121/4885MEN1 1938/4885KMT2A 290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.